BioVie Inc. Increase (Decrease) in Other Current Assets
BioVie Inc. (BIVI) reported Increase (Decrease) in Other Current Assets of $103.40 thousand for the 6-month period ending 2022-12-31, per its 10-Q filed 2023-02-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2023-02-10
- BioVie Inc. increase (decrease) in other current assets for the quarter ending 2022-12-31 was -$117.84K, a 340.76% decline year-over-year.
- BioVie Inc. increase (decrease) in other current assets for the quarter ending 2022-09-30 was $221.24K, a 1679.06% increase year-over-year.
- BioVie Inc. increase (decrease) in other current assets for the quarter ending 2021-12-31 was $48.95K, a 96.27% increase year-over-year.
- BioVie Inc. increase (decrease) in other current assets for the quarter ending 2021-09-30 was $12.44K, a 96.16% decline year-over-year.
- BioVie Inc. increase (decrease) in other current assets for fiscal 2022 was $48.95K.
- BioVie Inc. increase (decrease) in other current assets for fiscal 2021 was -$282.30K.
- BioVie Inc. increase (decrease) in other current assets for fiscal 2020 was -$41.63K.
- BioVie Inc. increase (decrease) in other current assets for fiscal 2019 was -$334.15K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 3 month as first filed | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 6 month as first filed | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month | Increase (Decrease) in Other Current Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | -$117.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10 | $103.40K 10-Q · filed 2023-02-10 | |||||
| 2022-09-30 | $221.24K 10-Q · filed 2022-11-04 | -$191.48K 10-Q · filed 2022-05-11 | |||||
| 2022-06-30 | $48.95K 10-K · filed 2022-09-27 | ||||||
| 2021-12-31 | $48.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10 | $61.38K 10-Q · filed 2023-02-10 | -$61.38K 10-Q · filed 2022-02-08 | -$553.85K derived: sum of 3 quarters · filed 2023-02-10 | -$569.45K derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-09-30 | $12.44K 10-Q · filed 2022-11-04 | -$12.44K 10-Q · filed 2021-11-10 | -$602.79K derived: sum of 2 quarters · filed 2022-11-04 | $332.93K 10-Q · filed 2022-05-11 | -$593.45K derived: sum of 4 quarters · filed 2022-11-04 | ||
| 2021-06-30 | -$615.23K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -$630.83K derived: sum of 2 quarters · filed 2022-09-27 | -$605.89K derived: sum of 3 quarters · filed 2022-09-27 | -$282.30K 10-K · filed 2022-09-27 | $282.30K 10-K · filed 2021-08-30 | ||
| 2021-03-31 | -$15.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-10 | $9.34K derived: sum of 2 quarters · filed 2022-02-08 | $332.93K 10-Q · filed 2021-05-10 | $534.33K derived: sum of 4 quarters · filed 2022-02-08 | |||
| 2020-12-31 | $24.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-08 | $348.53K 10-Q · filed 2022-02-08 | $549.92K derived: sum of 3 quarters · filed 2022-02-08 | $523.55K derived: sum of 4 quarters · filed 2022-02-08 | |||
| 2020-09-30 | $323.59K 10-Q · filed 2021-11-10 | $524.99K derived: sum of 2 quarters · filed 2021-11-10 | $498.62K derived: sum of 3 quarters · filed 2021-11-10 | $464.19K derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $201.40K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | $175.03K derived: sum of 2 quarters · filed 2021-08-30 | $140.59K derived: sum of 3 quarters · filed 2021-08-30 | -$41.63K 10-K · filed 2021-08-30 | |||
| 2020-03-31 | -$26.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-10 | -$60.80K derived: sum of 2 quarters · filed 2021-05-10 | -$243.03K 10-Q · filed 2021-05-10 | -$542.18K derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | -$34.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-29 | -$216.66K 10-Q · filed 2021-01-29 | -$515.81K derived: sum of 3 quarters · filed 2021-01-29 | ||||
| 2019-09-30 | -$182.23K 10-Q · filed 2020-11-05 | -$481.38K derived: sum of 2 quarters · filed 2020-11-05 | |||||
| 2019-06-30 | -$299.15K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | -$334.15K 10-K/A · filed 2020-08-07 | |||||
| 2019-03-31 | -$35.00K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |